DEF: Surgery Partners Seeks Stockholder Approval for 2025 Omnibus Incentive Plan

Surgery Partners is asking stockholders to approve the 2025 Omnibus Incentive Plan to replace the expiring 2015 plan and continue offering equity-based incentives.

Summary

• Surgery Partners is seeking stockholder approval for the 2025 Omnibus Incentive Plan to replace the expiring 2015 plan.
• The 2025 Incentive Plan aims to align the interests of key employees and directors with those of the company through performance-based and stock-based awards.
• The plan reserves 5,000,000 shares of common stock for future awards.
• If approved, the company will cease issuing new awards under the 2015 Incentive Plan, but existing awards will remain in effect.
• The plan allows for various types of awards, including stock options, stock appreciation rights, restricted stock, unrestricted stock, and stock units.
• The Compensation Committee will administer the plan and determine award terms, eligibility, and performance criteria.
• The plan includes individual limits on the number of shares that can be awarded to any one person in a calendar year.
• Non-employee director awards are limited to $400,000 in grant-date fair value, with an exception for a non-employee chairman or lead director, whose limit is $700,000.
• The plan outlines the treatment of awards in the event of a change in control or other corporate transactions.
• The plan includes provisions for adjusting awards in the event of stock splits, stock dividends, or other changes in capital structure.
• The plan is designed to comply with Section 409A and Section 422 of the Internal Revenue Code.
• The Board unanimously recommends that stockholders vote in favor of the 2025 Omnibus Incentive Plan.

Sentiment

Score: 7

Explanation: The document is a standard proxy statement proposal. The sentiment is neutral, focusing on the mechanics of the plan and its benefits. The plan is a positive for incentivizing employees and aligning their interests with shareholders.

Positives

• The 2025 Incentive Plan will allow Surgery Partners to continue to attract, retain, and motivate key employees and directors.
• The plan offers a variety of award types, providing flexibility in designing compensation packages.
• The plan includes provisions to align the interests of executives with those of stockholders.
• The plan is designed to comply with relevant tax regulations.

Risks

• Future awards under the 2025 Incentive Plan will be granted at the discretion of the Compensation Committee, making it impossible to determine the number and type of awards that will be granted to any person.
• The plan's effectiveness depends on the Compensation Committee's ability to administer it fairly and effectively.
• Changes in tax laws could impact the benefits of the plan.

Future Outlook

The authorized shares under the 2025 Incentive Plan are anticipated to provide enough shares for the next four to five years, based on projected share needs to execute the Company's long-term incentive program.

Industry Context

Equity-based compensation plans are a common practice in the healthcare industry to attract and retain talent and align their interests with those of the company's shareholders.

Stakeholder Impact

• Approval of the plan could positively impact shareholders by aligning management incentives with company performance.
• The plan is designed to attract, retain, and motivate key employees, which could benefit the company's overall performance.

Next Steps

• Stockholder vote on the approval of the 2025 Omnibus Incentive Plan at the annual meeting on June 6, 2025.

Keywords

incentive plan, equity compensation, stock options, restricted stock, performance awards, SARs, executive compensation, stockholder approval, compensation committee, Surgery Partners